- 4 days & nights inpatient stay
- 1 quick follow-up appointments
Participants will be reimbursed for their participation in this study and this clinical trial has been approved by an independent ethics committee.
About the study
This study is looking at a potential new treatment for seizures in patients with epilepsy. Epilepsy is one of the most common diseases of the central nervous system (CNS). It is characterised by spontaneous, recurrent seizures. This medication is predicted to provide anti-seizure effects but avoid causing side effects that are seen with other anti-seizure drugs.
The medication in this study is provided in capsules, which are about the size of multivitamin tablets. The purpose of this research is to assess how the drug is absorbed in the body (how much of the study drug gets into the blood stream and how long the body takes to clear it).
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Prevention Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!